Impact of automation on mass spectrometry

Clinica Chimica Acta

Volumn 450, Issue , 2015, Pages 298-303

  Zhang, Yan Victoria ^a   Rockwood, Alan ^b,c  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c ARUP LABORATORIES   (United States)

Author keywords

Automation; Clinical practices; High throughput; Liquid chromatography; Mass spectrometry; Routine clinical laboratories

Indexed keywords

ANALYZER; AUTOMATION; BIOCHEMICAL EQUIPMENT; BLOOD SAMPLING; CLINICAL LABORATORY; COST; DATA PROCESSING; HUMAN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PRIORITY JOURNAL; REVIEW; SAMPLING; SOLID PHASE EXTRACTION; STANDARDIZATION; TANDEM MASS SPECTROMETRY; ANALYSIS; ECONOMICS; PROCEDURES; STANDARD; STANDARDS;

ANALYTIC SAMPLE PREPARATION METHODS; AUTOMATION; CHROMATOGRAPHY, LIQUID; HUMANS; MASS SPECTROMETRY; REFERENCE STANDARDS;

EID: 84944174891     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2015.08.027     Document Type: Review

References (40)

1. Schulze A., Lindner M., Kohlmuller D., Olgemoller K., Mayatepek E., Hoffmann G.F. Expanded newborn screening for inborn errors of metabolism by electrospray ionization-tandem mass spectrometry: results, outcome, and implications. Pediatrics 2003, 111:1399-1406.
2. Wilcken B., Wiley V., Hammond J., Carpenter K. Screening newborns for inborn errors of metabolism by tandem mass spectrometry. N. Engl. J. Med. 2003, 348:2304-2312.
3. Mizuno T., Abe N., Teshima H., et al. Application of a gas chromatography mass spectrometry computer system for clinical diagnosis. Biomed. Mass Spectrom. 1981, 8:593-597.
4. Marquet P. Progress of liquid chromatography-mass spectrometry in clinical and forensic toxicology. Ther. Drug Monit. 2002, 24:255-276.
5. Maurer H.H. Current role of liquid chromatography-mass spectrometry in clinical and forensic toxicology. Anal. Bioanal. Chem. 2007, 388:1315-1325.
6. Fenn J.B., Mann M., Meng C.K., Wong S.F., Whitehouse C.M. Electrospray ionization for mass spectrometry of large biomolecules. Science (New York, NY) 1989, 246:64-71.
7. Kushnir M.M., Rockwood A.L., Bergquist J. Liquid chromatography-tandem mass spectrometry applications in endocrinology. Mass Spectrom. Rev. 2010, 29:480-502.
8. Streit F., Armstrong V.W., Oellerich M. Rapid liquid chromatography-tandem mass spectrometry routine method for simultaneous determination of sirolimus, everolimus, tacrolimus, and cyclosporin A in whole blood. Clin. Chem. 2002, 48:955-958.
9. Clarke N.J., Zhang Y., Reitz R.E. A novel mass spectrometry-based assay for the accurate measurement of thyroglobulin from patient samples containing antithyroglobulin autoantibodies. J. Investig. Med. 2012, 60:1157-1163.
10. Hoofnagle A.N., Roth M.Y. Clinical review: improving the measurement of serum thyroglobulin with mass spectrometry. J. Clin. Endocrinol. Metab. 2013, 98:1343-1352.
11. Kushnir M.M., Rockwood A.L., Roberts W.L., Abraham D., Hoofnagle A.N., Meikle A.W. Measurement of thyroglobulin by liquid chromatography-tandem mass spectrometry in serum and plasma in the presence of antithyroglobulin autoantibodies. Clin. Chem. 2013, 59:982-990.
12. Netzel B.C., Grebe S.K., Algeciras-Schimnich A. Usefulness of a thyroglobulin liquid chromatography-tandem mass spectrometry assay for evaluation of suspected heterophile interference. Clin. Chem. 2014, 60:1016-1018.
13. Claydon M.A., Davey S.N., Edwards-Jones V., Gordon D.B. The rapid identification of intact microorganisms using mass spectrometry. Nat. Biotechnol. 1996, 14:1584-1586.
14. Anderson L., Hunter C.L. Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins. Mol. Cell. Proteomics 2006, 5:573-588.
15. Vogeser M., Seger C. A decade of HPLC-MS/MS in the routine clinical laboratory-goals for further developments. Clin. Biochem. 2008, 41:649-662.
16. Hetu P.O., Robitaille R., Vinet B. Successful and cost-efficient replacement of immunoassays by tandem mass spectrometry for the quantification of immunosuppressants in the clinical laboratory. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2012, 883-884:95-101.
17. Clarke W., Rhea J.M., Molinaro R. Challenges in implementing clinical liquid chromatography-tandem mass spectrometry methods-the light at the end of the tunnel. J. Mass Spectrom. 2013, 48:755-767.
18. Honour J.W. Development and validation of a quantitative assay based on tandem mass spectrometry. Ann. Clin. Biochem. 2011, 48:97-111.
19. Grebe S.K., Singh R.J. LC-MS/MS in the clinical laboratory - where to from here?. Clin. Biochem. Rev. 2011, 32:5-31.
20. Vogeser M., Kirchhoff F. Progress in automation of LC-MS in laboratory medicine. Clin. Biochem. 2011, 44:4-13.
21. Adaway J.E., Keevil B.G., Owen L.J. Liquid chromatography tandem mass spectrometry in the clinical laboratory. Ann. Clin. Biochem. 2015, 52:18-38.
22. van den Ouweland J.M., Kema I.P. The role of liquid chromatography-tandem mass spectrometry in the clinical laboratory. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2012, 883-884:18-32.
23. Panteghini M. The future of laboratory medicine: understanding the new pressures. Clin. Biochem. Rev. 2004, 25:207-215.
24. Robandt P.P., Reda L.J., Klette K.L. Complete automation of solid-phase extraction with subsequent liquid chromatography-tandem mass spectrometry for the quantification of benzoylecgonine, m-hydroxybenzoylecgonine, p-hydroxybenzoylecgonine, and norbenzoylecgonine in urine-application to a high-throughput urine analysis laboratory. J. Anal. Toxicol. 2008, 32:577-585.
25. Poon E.G., Keohane C.A., Yoon C.S., et al. Effect of bar-code technology on the safety of medication administration. N. Engl. J. Med. 2010, 362:1698-1707.
26. Snyder M.L., Carter A., Jenkins K., Fantz C.R. Patient misidentifications caused by errors in standard bar code technology. Clin. Chem. 2010, 56:1554-1560.
27. Hawker C.D. Bar codes may have poorer error rates than commonly believed. Clin. Chem. 2010, 56:1513-1514.
28. Dickerson J.A., Schmeling M., Hoofnagle A.N., Hoffman N.G. Design and implementation of software for automated quality control and data analysis for a complex LC/MS/MS assay for urine opiates and metabolites. Clin. Chim. Acta 2013, 415:290-294.
29. Wu J.T. The development of a staggered parallel separation liquid chromatography/tandem mass spectrometry system with on-line extraction for high-throughout screening of drug candidates in biological fluids. Rapid Commun. Mass Spectrom. 2001, 15:73-81.
30. Xu R.N., Fan L., Rieser M.J., El-Shourbagy T.A. Recent advances in high-throughput quantitative bioanalysis by LC-MS/MS. J. Pharm. Biomed. Anal. 2007, 44:342-355.
31. Netzel B.C., Cradic K.W., Bro E.T., et al. Increasing liquid chromatography-tandem mass spectrometry throughput by mass tagging: a sample-multiplexed high-throughput assay for 25-hydroxyvitamin D2 and D3. Clin. Chem. 2011, 57:431-440.
32. Grote-Koska D., Czajkowski S., Brand K. Performance of the new RapidFire(R) system for therapeutic monitoring of immunosuppressants. Ther. Drug Monit. 2014.
33. Gutman S. The role of Food and Drug Administration regulation of in vitro diagnostic devices-applications to genetics testing. Clin. Chem. 1999, 45:746-749.
34. Scott M.G., Ashwood E.R., Annesley T.M., Leonard D.G., Burgess M.C. FDA oversight of laboratory-developed tests: is it necessary, and how would it impact clinical laboratories?. Clin. Chem. 2013, 59:1017-1022.
35. Vogeser M., Seger C. Pitfalls associated with the use of liquid chromatography-tandem mass spectrometry in the clinical laboratory. Clin. Chem. 2010, 56:1234-1244.
36. Yates A.M., Bowron A., Calton L., et al. Interlaboratory variation in 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 is significantly improved if common calibration material is used. Clin. Chem. 2008, 54:2082-2084.
37. Carter G.D. 25-Hydroxyvitamin D assays: the quest for accuracy. Clin. Chem. 2009, 55:1300-1302.
38. Levine D.M., Maine G.T., Armbruster D.A., et al. The need for standardization of tacrolimus assays. Clin. Chem. 2011, 57:1739-1747.
39. Napoli K.L., Hammett-Stabler C., Taylor P.J., et al. Multi-center evaluation of a commercial kit for tacrolimus determination by LC/MS/MS. Clin. Biochem. 2010, 43:910-920.
40. Carter G.D., Jones J.C. Use of a common standard improves the performance of liquid chromatography-tandem mass spectrometry methods for serum 25-hydroxyvitamin-D. Ann. Clin. Biochem. 2009, 46:79-81.